Inventor
WRIGHT CURTIS
US82 patents
⚠️ This page may combine multiple inventors who share the name “WRIGHT CURTIS”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PURDUE PHARMA LP
38 patentsUS9060976B2Jun 23, 2015
Pharmaceutical formulation containing gelling agent
PURDUE PHARMA LP72 citations99
US9044435B2Jun 2, 2015
Pharmaceutical formulation containing gelling agent
PURDUE PHARMA LP55 citations99
US9040084B2May 26, 2015
Pharmaceutical formulation containing gelling agent
PURDUE PHARMA LP38 citations99
US9034376B2May 19, 2015
Pharmaceutical formulation containing gelling agent
PURDUE PHARMA LP48 citations99
US8999961B2Apr 7, 2015
Pharmaceutical formulation containing gelling agent
PURDUE PHARMA LP41 citations99
US8871265B2Oct 28, 2014
Pharmaceutical formulation containing gelling agent
PURDUE PHARMA LP51 citations99
US8609683B2Dec 17, 2013
Pharmaceutical formulation containing gelling agent
PURDUE PHARMA LP85 citations99
US8529948B1Sep 10, 2013
Pharmaceutical formulation containing gelling agent
PURDUE PHARMA LP80 citations99
US7842307B2Nov 30, 2010
Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agent
PURDUE PHARMA LP221 citations99
US7658939B2Feb 9, 2010
Tamper-resistant oral opioid agonist formulations
PURDUE PHARMA LP176 citations99
US9387173B2Jul 12, 2016
Pharmaceutical formulation containing gelling agent
PURDUE PHARMA LP27 citations98
US9387174B2Jul 12, 2016
Pharmaceutical formulation containing gelling agent
PURDUE PHARMA LP26 citations98
US9308171B2Apr 12, 2016
Pharmaceutical formulation containing gelling agent
PURDUE PHARMA LP25 citations98
US9308170B2Apr 12, 2016
Pharmaceutical formulation containing gelling agent
PURDUE PHARMA LP24 citations98
US7914818B2Mar 29, 2011
Opioid agonist formulations with releasable and sequestered antagonist
PURDUE PHARMA LP46 citations98
US7842311B2Nov 30, 2010
Tamper-resistant oral opioid agonist formulations
PURDUE PHARMA LP52 citations98
US7790215B2Sep 7, 2010
Sustained-release gel coated compositions
PURDUE PHARMA LP89 citations98
US7141250B2Nov 28, 2006
Pharmaceutical formulation containing bittering agent
PURDUE PHARMA LP224 citations98
US7846476B2Dec 7, 2010
Once-a-day oxycodone formulations
PURDUE PHARMA LP63 citations96
US7842309B2Nov 30, 2010
Tamper-resistant oral opioid agonist formulations
PURDUE PHARMA LP28 citations96
US7718192B2May 18, 2010
Tamper-resistant oral opioid agonist formulations
PURDUE PHARMA LP41 citations96
US7682632B2Mar 23, 2010
Tamper-resistant oral opioid agonist formulations
PURDUE PHARMA LP41 citations96
US10206881B2Feb 19, 2019
Pharmaceutical formulation containing gelling agent
PURDUE PHARMA LP7 citations93
US10076497B2Sep 18, 2018
Pharmaceutical formulation containing gelling agent
PURDUE PHARMA LP6 citations93
US10071057B2Sep 11, 2018
Pharmaceutical formulation containing gelling agent
PURDUE PHARMA LP6 citations93
US10064824B2Sep 4, 2018
Pharmaceutical formulation containing gelling agent
PURDUE PHARMA LP6 citations93
US9877924B2Jan 30, 2018
Pharmaceutical formulation containing gelling agent
PURDUE PHARMA LP4 citations93
US9872836B2Jan 23, 2018
Pharmaceutical formulation containing gelling agent
PURDUE PHARMA LP8 citations93
US9757341B2Sep 12, 2017
Pharmaceutical formulation containing gelling agent
PURDUE PHARMA LP4 citations93
US9693961B2Jul 4, 2017
Pharmaceutical formulation containing gelling agent
PURDUE PHARMA LP7 citations93
US9517207B2Dec 13, 2016
Pharmaceutical formulation containing gelling agent
PURDUE PHARMA LP6 citations93
US9101668B2Aug 11, 2015
Pharmaceutical formulation containing opioid agonist, opioid antagonist and gelling agent
PURDUE PHARMA LP12 citations93
US7413749B2Aug 19, 2008
Titration dosing regimen for controlled release tramadol
PURDUE PHARMA LP42 citations93
US8936812B2Jan 20, 2015
Tamper-resistant oral opioid agonist formulations
PURDUE PHARMA LP6 citations92
US8586088B2Nov 19, 2013
Tamper-resistant oral opioid agonist formulations
PURDUE PHARMA LP13 citations92
US8357399B2Jan 22, 2013
Tamper-resistant oral opioid agonist formulations
PURDUE PHARMA LP17 citations92
US7943173B2May 17, 2011
Pharmaceutical combinations of oxycodone and naloxone
PURDUE PHARMA LP27 citations92
US9034377B2May 19, 2015
Opioid dosage forms having dose proportional steady state Cave and AUC and less than dose proportional single dose Cmax
PURDUE PHARMA LP19 citations89
EURO CELTIQUE SA
4 patentsUS6716449B2Apr 6, 2004
Controlled-release compositions containing opioid agonist and antagonist
EURO CELTIQUE SA252 citations99
US6696088B2Feb 24, 2004
Tamper-resistant oral opioid agonist formulations
EURO CELTIQUE SA456 citations99
US6682757B1Jan 27, 2004
Titratable dosage transdermal delivery system
EURO CELTIQUE SA176 citations99
US7144587B2Dec 5, 2006
Pharmaceutical formulation containing opioid agonist, opioid antagonist and bittering agent
EURO CELTIQUE SA216 citations98
WRIGHT CURTIS
3 patentsBREDER CHRISTOPHER
3 patentsUS8465774B2Jun 18, 2013
Sequestered antagonist formulations
BREDER CHRISTOPHER52 citations97
US8518443B2Aug 27, 2013
Opioid agonist formulations with releasable and sequestered antagonist
BREDER CHRISTOPHER22 citations92
US8231901B2Jul 31, 2012
Opioid agonist formulations with releasable and sequestered antagonist
BREDER CHRISTOPHER20 citations92
OSHLACK BENJAMIN
2 patentsShowing the top 50 of 82 patents by PatentIndex Score.